BioClinica Holding I, LP
BioClinica Holding I, LP, a prominent player in the clinical research and imaging industry, is headquartered in the United States. Founded in 1988, the company has established itself as a leader in providing comprehensive solutions for clinical trials, particularly in the areas of imaging, cardiac safety, and data management. With a strong operational presence across North America and Europe, BioClinica offers a unique blend of advanced technology and expert services that streamline the clinical development process. Their core offerings include imaging services, clinical trial management, and regulatory consulting, all designed to enhance the efficiency and accuracy of clinical studies. Recognised for its commitment to quality and innovation, BioClinica has achieved significant milestones, positioning itself as a trusted partner for pharmaceutical and biotechnology companies worldwide.
DitchCarbon Score
How does BioClinica Holding I, LP's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
BioClinica Holding I, LP's score of 23 is lower than 64% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
BioClinica Holding I, LP's reported carbon emissions
BioClinica Holding I, LP, headquartered in the US, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Furthermore, there are no documented reduction targets or climate pledges associated with the organisation. This lack of data suggests that BioClinica may not have established formal commitments to reduce its carbon footprint or engage in climate initiatives at this time. As a result, the company does not appear to be actively participating in industry-standard climate frameworks such as the Science Based Targets initiative (SBTi) or similar programmes.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
BioClinica Holding I, LP is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
